Susan Thompson Buffett Foundation

Recent papers from Susan Thompson Buffett Foundation

1. Rethinking Treatment Intensification in Poorly Chemosensitive Ovarian CancerJAMA Oncology · 2026
2. Evaluation of an Online One-Month Whole-Food Plant-Based Dietary InterventionAmerican Journal of Lifestyle Medicine · 2026
3. The Inv(16) Oncogene CBFB::MYH11 is Required for the Survival of Leukemia Cells in the Blood and Spleen, but not the Bone MarrowOncogene · 2026
4. 83RO Trastuzumab pamirtecan (T-Pam/DB-1303/BNT323) in patients (pts) with previously treated, HER2-expressing, advanced endometrial cancer (EC): Overall survival (OS) and efficacy in pt subgroups of a phase II dose-expansion cohortESMO Open · 2026
5. Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In OncologyJournal of the National Comprehensive Cancer Network · 2026
6. Burden and site-specific spectrum of second primary malignancies after adult acute myeloid leukemia: A population-based SEER standardized incidence ratio study with latency-stratified risk profiling (2000–2022).Journal of Clinical Oncology · 2026
7. NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026Journal of the National Comprehensive Cancer Network · 2026
8. Molecular analysis of a new patient COX15 mutation provides insight into the etiology of fatal infantile cardioencephalopathyJournal of Biological Chemistry · 2026
9. Non–Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyJournal of the National Comprehensive Cancer Network · 2026
10. NCCN Guidelines® Insights: Distress Management, Version 1.2026Journal of the National Comprehensive Cancer Network · 2026
11. Tumor Lipidomic Changes after Treatment with Polymeric Hydroxychloroquine in a Syngeneic Murine Model of Pancreatic CancerACS Omega · 2026
12. NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026Journal of the National Comprehensive Cancer Network · 2026
13. Role of Intermediate dose escalation of radiotherapy in the survival of unresectable stage III non-small cell lung cancer patients in the era of immunotherapySHILAP Revista de lepidopterología · 2026
14. Spatial Proteomics of the Normal Breast Collagen Stroma: Links to Density and Body Mass IndexJournal of Proteome Research · 2026
15. Dynamic Shifts in ER–Plasma Membrane Junctions Signaling Define Pro‐Metastatic N‐Glycosylation and Predict Prostate Cancer ProgressionAdvanced Science · 2026
16. Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunityCommunications Biology · 2026
17. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026Journal of the National Comprehensive Cancer Network · 2026
18. Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In OncologyJournal of the National Comprehensive Cancer Network · 2026
19. The S180R Human Germline Variant of DNA Polymerase β Is a Low Fidelity Enzyme with Reduced Flexibility of the Fingers DomainBiochemistry · 2026
20. Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In OncologyJournal of the National Comprehensive Cancer Network · 2026